Article
Document
Anualidad
Information Content Entity
Continuant
Entity
Congress communication
Generically Dependent Continuant
Conference Paper
Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.
American Society of Clinical Oncology 39th Annual Meeting
RDF description of Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors. - http://research.umh.es/vivo/pub/comunicacion/22050